No funder had any role in study design, data collection or interpretation, or writing of the manuscript
and (3) Primary and secondary outcomes as predefined (e.g., CV death, MACE, expanded MACE, nonfatal MI, nonfatal stroke, hospitalization for HF, SBP/DBP, LDL/HDL, eGFR, and UACR)
doi: 10.1093/ecco-jcc/jjae082 2 BertinLCrepaldiMZanconatoMLorenzonGManieroDde BarbaCet al
In trials to assess semaglutides effectiveness for reducing the risk of major cardiovascular events in adults, more people taking Wegovy developed kidney stones than those on placebo 1.2% vs 0.8% respectively
Politique de retours Le retour sous 90 jours gratuit est disponible pour les clients ayants effectus au moins un achat par le pass sur le site, cela pour viter les retours abusifs